000 | 01882 a2200529 4500 | ||
---|---|---|---|
005 | 20250515214409.0 | ||
264 | 0 | _c20100608 | |
008 | 201006s 0 0 eng d | ||
022 | _a1945-7170 | ||
024 | 7 |
_a10.1210/en.2010-0160 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTammali, Ravinder | |
245 | 0 | 0 |
_aAldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle. _h[electronic resource] |
260 |
_bEndocrinology _cMay 2010 |
||
300 |
_a2140-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAldehyde Reductase _xantagonists & inhibitors |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta _xmetabolism |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCyclins _xgenetics |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xgenetics |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aE2F1 Transcription Factor _xgenetics |
650 | 0 | 4 | _aG1 Phase |
650 | 0 | 4 |
_aGlucose _xpharmacology |
650 | 0 | 4 |
_aImidazolidines _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRetinoblastoma Protein _xmetabolism |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aS Phase |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
700 | 1 | _aSaxena, Ashish | |
700 | 1 | _aSrivastava, Satish K | |
700 | 1 | _aRamana, Kota V | |
773 | 0 |
_tEndocrinology _gvol. 151 _gno. 5 _gp. 2140-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/en.2010-0160 _zAvailable from publisher's website |
999 |
_c19671781 _d19671781 |